Showing results (481-490 of 887) with videos related to
Sort By:
Pageof 89
Clinical Kidney Journal|August 14, 2024
Reduction in kidney function decline and risk of severe clinical events in agalsidase beta-treated Fabry disease patients: a matched analysis from the Fabry RegistryJulie L Batista, Ali Hariri, Manish Maski, et al.JACC. Cardiovascular Imaging|June 18, 2011
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessmentMarkus Niemann, Sebastian Herrmann, Kai Hu, et al.Atherosclerosis|August 3, 2007
Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen speciesSusanne B Schwedler, Peter J Kuhlencordt, P Padmapriya Ponnuswamy, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 17, 2009
Association of body mass index with decline in residual kidney function after initiation of dialysisChristiane Drechsler, Renée de Mutsert, Diana C Grootendorst, et al.Diabetes Research and Clinical Practice|May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trialSilvio E Inzucchi, Christoph Wanner, David Fitchett, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 27, 2014
Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysisChantal Kopecky, Bernd Genser, Christiane Drechsler, et al.Kidney International|February 12, 2015
Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal diseaseChristiane Drechsler, Sahir Kalim, Julia B Wenger, et al.Journal of Medical Genetics|June 12, 2020
Treatment switch in Fabry disease- a matter of dose?Malte Lenders, Peter Nordbeck, Sima Canaan-Kühl, et al.Heart (British Cardiac Society)|October 23, 2010
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapyMarkus Niemann, Frank Breunig, Meinrad Beer, et al.Plos One|April 21, 2015
Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal diseaseMartin Wagner, Damien R Ashby, Caroline Kurtz, et al.Pageof 89